Clinical and Electrocardiographic Predictors of Recurrent Atrial Fibrillation
Corresponding Author
POLYCHRONIS E. DILAVERIS
From the State Department of Cardiology, Hippokration Hospital, and the Department of Cardiology, 251 Air Force Hospital, Athens, Greece
Address for reprints: Polycbronis E. Dilaveris, M.D., 22 Miltiadou Str., GR-155B1 Holargos, Athens, Greece. Fax (+301)-6531377; e-mail: [email protected]Search for more papers by this authorELIAS J. GIALAFOS
From the State Department of Cardiology, Hippokration Hospital, and the Department of Cardiology, 251 Air Force Hospital, Athens, Greece
Search for more papers by this authorGEORGE K. ANDRIKOPOULOS
From the State Department of Cardiology, Hippokration Hospital, and the Department of Cardiology, 251 Air Force Hospital, Athens, Greece
Search for more papers by this authorDIMITRIS J. RICHTER
From the State Department of Cardiology, Hippokration Hospital, and the Department of Cardiology, 251 Air Force Hospital, Athens, Greece
Search for more papers by this authorVASILIOS PAPANIKOLAOU
From the State Department of Cardiology, Hippokration Hospital, and the Department of Cardiology, 251 Air Force Hospital, Athens, Greece
Search for more papers by this authorKONSTANTINOS PORALIS
From the State Department of Cardiology, Hippokration Hospital, and the Department of Cardiology, 251 Air Force Hospital, Athens, Greece
Search for more papers by this authorJOHN E. GIALAFOS
From the State Department of Cardiology, Hippokration Hospital, and the Department of Cardiology, 251 Air Force Hospital, Athens, Greece
Search for more papers by this authorCorresponding Author
POLYCHRONIS E. DILAVERIS
From the State Department of Cardiology, Hippokration Hospital, and the Department of Cardiology, 251 Air Force Hospital, Athens, Greece
Address for reprints: Polycbronis E. Dilaveris, M.D., 22 Miltiadou Str., GR-155B1 Holargos, Athens, Greece. Fax (+301)-6531377; e-mail: [email protected]Search for more papers by this authorELIAS J. GIALAFOS
From the State Department of Cardiology, Hippokration Hospital, and the Department of Cardiology, 251 Air Force Hospital, Athens, Greece
Search for more papers by this authorGEORGE K. ANDRIKOPOULOS
From the State Department of Cardiology, Hippokration Hospital, and the Department of Cardiology, 251 Air Force Hospital, Athens, Greece
Search for more papers by this authorDIMITRIS J. RICHTER
From the State Department of Cardiology, Hippokration Hospital, and the Department of Cardiology, 251 Air Force Hospital, Athens, Greece
Search for more papers by this authorVASILIOS PAPANIKOLAOU
From the State Department of Cardiology, Hippokration Hospital, and the Department of Cardiology, 251 Air Force Hospital, Athens, Greece
Search for more papers by this authorKONSTANTINOS PORALIS
From the State Department of Cardiology, Hippokration Hospital, and the Department of Cardiology, 251 Air Force Hospital, Athens, Greece
Search for more papers by this authorJOHN E. GIALAFOS
From the State Department of Cardiology, Hippokration Hospital, and the Department of Cardiology, 251 Air Force Hospital, Athens, Greece
Search for more papers by this authorAbstract
Patients with frequent episodes of paroxysmal atrial fibrillation (AF) are prone to develop permanent AF and have an increased thromboembolic risk. We have previously shown that P wave dispersion (P dispersion), defined as the difference between the maximum and the minimum P wave duration, and maximum P wave duration (P maximum) can distinguish patients with paroxysmal lone AF. The ability of those ECG markers and of other clinical and ECG variables to detect patients at risk for recurrent AF was tested in 88 patients, aged 64 ± 12 years. All patients had a history of symptomatic episodes of AF during the last 2 years and had not previously received any antiarrhythmic prophylaxis. P maximum and P dispersion were calculated from a 12-lead surface ECG recorded in all patients during sinus rhythm. A computerized ECG system was used and P maximum and P dispersion were calculated on screen from the averaged complexes of all 12 leads. Age (P=0.01), history of organic heart disease (P = 0.03), P maximum (P < 0.001), minimum P wave duration (P = 0.05), and P dispersion (P < 0.001) were found to be significant univariate predictors of recurrent AF, whereas only P maximum (P < 0.001) and age (P = 0.037) remained significant independent predictors of frequent AF paroxysms in the multivariatfi analysis. It is concluded that advanced age and prolonged P wave duration may be used as predictors of frequently relapsing AF. Therefore, simple AF predictors exist that could possibly distinguish the patients in whom prophylaxis with antiarrhythmic medicines should be instituted.
References
- 1 Kannel WB, Abbott RD, Savage DD, et al. Epidemiological features of chronic atrial fibrillation: The Framingham Study. N Engl J Med 1982; 306: 1018–1022.
- 2 Alpert JS, Petersen P, Godtfredsen J. Atrial fibrillation: Natural history, complications, and management. Annu Rev Med 1988; 39: 41–52.
- 3 Kannol WB, Abbott RD, Savage DD, et al. Coronary heart disease and alrial fibrillulion: The Framingham Study. Am Heart J 1983; 106: 389–396.
- 4 Lip GYH. Does paroxysmal atrial fibrillation confer a paroxysmal thromboembolic risk Lancet 1997; 349: 1565–1566.
- 5 Bennett D. Alrial fibrillation. Eur Heart J 1984; 5(Suppl. A): 89–93.
- 6 Cobbe SM. Using the right drug. A treatment algorithm for atrial fibrillation. Eur Heart J 1997; 18(Suppl.): C33–C39.
- 7 Flaker GC, Fletcher KA, Rothhart RM, et al. Clinical and echocar-diographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation. Am J Cardiol 1995; 76: 355–358.
- 8 Turitto G, Bandarizadeh B, Salciccioli L, et al. Risk stratification for recurrent tachyarrhythmias in patients with paroxysmal atrial fibrillation and flutter: Role of signal averaged electrocardiogram and echocardiography. PACE 1998; 21: 197–201.
- 9 Suttorp MJ, Kingma H, Koomen EM, et al. Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. Am I Cardiol 1993; 71: 710–713.
- 10 Brodsky MA, Allen BJ, Capparelli EV, et al. Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation. Am J Cardiol 1989; 63: 1065–1068.
- 11 Dittrich HC, Erickson JS, Schneiderman T, et al. Echocardiographic and clinical predictors for outcome of eleclive cardioversion of atrial fibrillation. Am J Cardiol 1989; 63: 193–197.
- 12 Ewy GA, Ulfers L, Hager WD, et al. Response of atrial fibrillation to therapy, role of etiology and left atrial size. J Electrocardiol 1980; 13: 119–124.
- 13 Henry WL, Morganroth J, Pearhnan AS, et al. Relation between echocardiographically determined left alrial size and atrial fibrillation. Circulation 1976; 53: 273–279.
- 14 Michelucci A, Padeletti L, Chelucci A, et al. Influence of age, lead axis, frequency of arrhythmic episodes, and atrial dimensions on P wave triggered SAECG in patients with lone paroxysmal atrial fibrillation. PACE 1996; 19: 758–767.
- 15 Kerr GR, Boons J, Connolly SJ, et al The Canadian registry of atrial fibrillation: A noninterventional follow-up of patients after the first diagnosis of alrial fibrillation. Am J Cardiol 1998; 82: 82N–85N.
- 16 Montereggi A, Marconi P, Olivotto I, et al. Signal-averaged P-wave duration and risk of paroxysmal atrial fibrillation in hyperthyroidism. Am J Cardiol 1996; 77: 266–269.
- 17 Guidera S, Steinberg J. The signal-averaged P wave duration: A rapid and noninvasive marker of risk of atrial fibrillation. J Am Coil Gardiol 1993; 21: 1645–1651.
- 18
Falk RH,
Pollak A.
Signal-averaged P wave duration and strial fibrillation.
J Am Coll Cardiol
1994; 23: 548–551.
10.1016/0735-1097(94)90448-0 Google Scholar
- 19 Fukunami M, Yamada T, Ohmori M, et al. Deteclion of patients at risk for paroxysmal atrial fibrillation during sinus rhythm by P wave-triggered signal-averaged electrocardiogram. Circulation 1991; 83: 162–169.
- 20 Stafford PJ, Robinson D, Vincent R. Optimal analysis of the signal averaged P wave in patients with paroxysmal atrial fibrillation. Br Heart J 1995; 74: 413–418.
- 21 Seifert M, Josephson ME, P-wave signal averaging. High tech or an expensive alternative to the standard ECG Circulation 1993; 88: 2980–2982.
- 22 Dilaveris P, Gialafos E, Sideris S, et al Simple electrocardiographic markers for the prediction of idiopathic paroxysmal atrial fibrillation. (abstract) PACE 1997; 20(Pt II): 1098.
- 23 Dilaveris PE, Gialafos EJ, Sideris S, et al. Simple eleclronardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998; 135: 733–738.
- 24
Gialafos JE,
Dilaveris PE,
Gialafos EJ, et al.
P-wave dispersion: A valuable electrocardiographic marker for the prediction of paroxysmal lone atrial fibrillation.
Ann Noninvas Electrocardiol
1999; 4: 39–45.
10.1111/j.1542-474X.1999.tb00363.x Google Scholar
- 25 Alt E, Ammer R, Lehmann G, et al. Patient characteristics and underlying heart disease as predictors of recurrent atrial fibrillation after internal and external cardioversion in patients treated with oral sotalol. Am Heart J 1997; 134: 419–425.
- 26 Van Bemmel JH, Kors JA, Van Herpen G. Methodology of the modular ECG analysis system MEANS. Methods Inf Med 1990; 29: 346–353.
- 27 Van Bemmel JH, Zywietz C, Kors JA. Signal analysis for ECG interpretation. Methods Inf Med. 1990; 29: 317–329.
- 28 Dilaveris PE, Andrikopoulos GK, Melaxas G, et al. Effects of ischemia on P wave dispersion and maximum P wave duration during spontaneous anginal episodes. PACE 1999; 22: 1640–1647.
- 29 Buxton AE, Josephson ME. The role of P wave duration as a predictor of postoperative atrial arrhythmias. Chest 1981; 80: 68–73.
- 30 Stafford PJ, Turner I, Vincent R. Quantitative analysis of signal-averaged P waves in idiopathic paroxysmal atrial fibrillation. Am J Cardiol 1991; 68: 751–755.
- 31 Klein M, Evans SJL., Blumberg S, et al. Use of P-wave-triggered, P-wave signal-averaged electrocardiogram to predict atrial fibrillation after coronary artery bypass surgery. Am Heart J 1995; 129: 895–901.
- 32 Kloter Weber U, Osswald S, Huber M, etal . Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: Is there a need for pre-operative risk stratification? A prospective placebo-controlled study using low-dose sotalol. Eur Heart J 1998; 19: 794–800.
- 33
Coumel P.
Electrophysiology, pacing, and arrhythmia. Clinical approach to paroxysmal atrial fibrillation.
Clin Cardiol
1990; 13: 209–212.
10.1002/clc.4960130311 Google Scholar
- 34 Wang J, Bourne GW, Wang Z, et al. Comparative mechanisms of antiarrhythmic drug action on experimental atrial fibrillation. Importance of use-dependent effects on refractoriness. Circulation 1993; 88: 1030–1044.
- 35 Allessie MA, Wijffels MC, Dorland K. Mechanisms of pharmacologic cardioversion of atrial fibrillation by Class I drugs. J Cardiovasc Electrophysiol 1998; 9(Suppl.): S69–77.
- 36 Prystowsky EN, Katz A. Atrial fibrillation. In EJ Topol (ed.): Text-hook of Cardiovascular Medicine. Philadelphia , Lippincutl-Raven Publishers, 1998; pp. 1661–1693.
- 37
Dittrich HC,
Pearce LA,
Asinger RW, et al.
Left atrial diameter in nonvalvular atrial fibrillation: An echocardiographic study.
Am Heart J
1999; 137: 494–499.
10.1016/S0002-8703(99)70498-9 Google Scholar
- 38 Josephson ME, Kastor JA, Morganroth J. Electrocardiographic left atrial enlargement: Electrophysiologic, echocardiographic and hemodynamic correlates. Am J Cardiol 1977; 39: 967–971.
- 39 Frost L, Lund B, Pilegaard H, et al. Re-evaluation of the role of P-wave duration and morphology as predictors of atrial fibrillation and flutter after coronary artery bypass surgery. Eur Heart J 1996; 17: 1065–1071.
- 40 Allessie MA, Bonke FIM, Schopman FJG. Circus movement in rabhit atrial muscle as a mechanism of tachycardia. II: The role of nonuiform recovery of excitability in the occurrence of unidirectional block as studied with multiple microelectrodes. Circ Res 1976; 39: 168–177.
- 41 Gencel L, Poquet F, Gosse P, et al Correlation of signal-averaged P wave with electrophysiologkal testing for atrial vulnerability in strokes of unexplained etiology. PACE 1994; 17(Pt.II): 2118–2124.